LY2801653,
N-(3-fluoro-4-((1-methyl-6-(1H-pyrazol-4-yl)-1H-indazol-5 yl)oxy)phenyl)-1-(4-fluorophenyl)-6-methyl-2-oxo-1,2-dihydropyridine-3-carboxamide,
Merestinib,
LY2801653,
1206799-15-6,
LY-2801653,
UNII-5OGS5K699E,
N-(3-fluoro-4-((1-methyl-6-(1H-pyrazol-4-yl)-1H-indazol-5-yl)oxy)phenyl)-1-(4-fluorophenyl)-6-methyl-2-oxo-1,2-dihydropyridine-3-carboxamide,
5OGS5K699E,
N-(3-Fluoro-4-{[1-Methyl-6-(1h-Pyrazol-4-Yl)-1h-Indazol-5-Yl]oxy}phenyl)-1-(4-Fluorophenyl)-6-Methyl-2-Oxo-1,2-Dihydropyridine-3-Carboxamide,
C30H22F2N6O3,
N-(3-Fluoro-4-(1-methyl-6-(1H-pyrazol-4-yl)-1H-indazol-5-yloxy)phenyl)-1-(4-fluorophenyl)-6-methyl-2-oxo-1,2-dihydropyridine-3-carboxamide,
N-[3-Fluoro-4-[[1-methyl-6-(1H-pyrazol-4-yl)-1H-indazol-5-yl]oxy]phenyl]-1-(4-fluorophenyl)-1,2-dihydro-6-methyl-2-oxo-3-pyridinecarboxamide,
N-[3-fluoro-4-[1-methyl-6-(1H-pyrazol-4-yl)indazol-5-yl]oxyphenyl]-1-(4-fluorophenyl)-6-methyl-2-oxopyridine-3-carboxamide,
Merestinib [USAN],
ly2801653-merestinib,
SCHEMBL679002,
LY2801653 (Merestinib),
Merestinib (LY2801653),
GTPL9841,
CHEMBL3545307,
DTXSID20659635,
QCR-139,
SYN1222,
QHADVLVFMKEIIP-UHFFFAOYSA-N,
BCP06826,
EX-A1264,
KS-00000SA6,
3797AH,
BDBM50172078,
s7014,
ZINC95926668,
AKOS027323283,
CS-1192,
DB12381,
SB16550,
NCGC00378921-02,
NCGC00378921-07,
3-Pyridinecarboxamide, N-(3-fluoro-4-((1-methyl-6-(1H-pyrazol-4-yl)-1H-indazol-5-yl)oxy)phenyl)-1-(4-fluorophenyl)-1,2-dihydro-6-methyl-2-oxo-,
AK315242,
AS-16348,
HY-15514,
AB0095019,
FT-0745076,
LY 2801653,
J3.563.073B,
W-6007,
L1X,
D06EGV,
A3573,
A12557,